From Australia to China: CTI's APAC Growth Journey

<p>Asia Pacific has become one of the fastest-growing regions in clinical research, offering sponsors new opportunities to advance clinical development in an increasingly complex global environment.</p><p>In this episode, Pavels Anetko, Director of Clinical Operations and Clinical Project Management at CTI, shares insights from across the region, including Australia&#39;s strengths in early phase studies and CTI&#39;s recent expansion into China and Japan.</p><p> </p><p> </p><p><strong>01:24</strong> Pavels’ background, career journey, and leadership role overseeing CTI&#39;s project management teams across Asia Pacific. </p><p><strong>02:13</strong> Why APAC is one of the fastest-growing regions for clinical development and the increasing influence of China. </p><p><strong>02:41</strong> CTI&#39;s growth strategy in Australia and the region&#39;s advantages for early-phase research, including the CTN regulatory pathway and R&amp;D tax incentives. </p><p><strong>04:06</strong> The rise of healthy volunteer and Phase I studies in Australia. </p><p><strong>04:27</strong> Building CTI&#39;s presence in China and Japan and navigating more complex regulatory environments. </p><p><strong>05:05</strong> Staying aligned with regional regulatory requirements while maintaining global clinical trial standards. </p><p><strong>05:40</strong> How CTI helps sponsors select the right countries, sites, and patient populations across APAC. </p><p><strong>06:20</strong> Why local infrastructure, language expertise, and in-country teams are critical to trial success. </p><p><strong>07:09</strong> Challenges sponsors face when entering new APAC markets and how local support reduces risk. </p><p><strong>07:36</strong> The strategic value of including Japan and China in global studies, including access to patients and regulatory considerations. </p><p><strong>08:58</strong> How APAC can accelerate development timelines and strengthen regulatory submissions. </p><p><strong>09:38</strong> Key operational considerations for global studies, including logistics, specimen handling, and country-specific requirements.  </p><p><strong>10:08</strong> Emerging opportunities across APAC, including growth in Southeast Asia and expanding clinical research markets.  </p><p><strong>10:54</strong> Pavels shares career highlights, including gene therapy studies in Australia and supporting COVID-19 vaccine trials in Singapore.  </p><p><strong>12:44</strong> Closing thoughts on the future of APAC and its growing influence on global clinical development.</p>